Bafna Pharmaceuticals share news, announcements and annual reports
NSE: BAFNAPHBSE: 532989Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹442.75.
28 Oct: open ₹451.60, high ₹451.60, low ₹451.60
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,068 Cr2,105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 137.21
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 11.11
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 11,610
Bafna Pharmaceuticals has 637 announcements on record, routine notices left out; none in the 30 days to 29 Oct 2026, the latest on 11 Sep 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Bafna Pharmaceuticals quarterly results
The board met on 11 Aug 2026 to consider financial results and quarterly results
Notice filed 5 Aug 2026
To consider and approve the Un-Audited financial results for the Quarter ended June 30, 2026
Bafna Pharmaceuticals annual reports, presentations and earnings calls
The company's own documents, latest first.Bafna Pharmaceuticals financials, year by year
Annual reports26
- Annual report, year to Mar 202619 Aug 2026
- Annual report, year to Mar 202619 Aug 2026
- Annual report, year to Mar 202526 Aug 2025
- Annual report, year to Mar 202526 Aug 2025
- Annual report, year to Mar 20242 Sep 2024
21 earlier reports
- Annual report, year to Mar 20242 Sep 2024
- Annual report, year to Mar 202330 Aug 2023, a zip file
- Annual report, year to Mar 202330 Aug 2023
- Annual report, year to Mar 20226 Jul 2022, a zip file
- Annual report, year to Mar 20226 Jul 2022
- Annual report, year to Mar 202122 Jul 2021, a zip file
- Annual report, year to Mar 202122 Jul 2021
- Annual report, year to Mar 20209 Jul 2020, a zip file
- Annual report, year to Mar 20196 Jun 2019
- Annual report, year to Mar 20183 Oct 2018
- Annual report, year to Mar 20171 Nov 2017
- Annual report, year to Mar 20166 Oct 2016
- Annual report, year to Mar 20158 Sep 2015
- Annual report, year to Mar 201413 Aug 2014
- Annual report, year to Mar 20135 Sep 2013
- Annual report, year to Mar 2012Filing day not known
- Annual report, year to Mar 20118 Dec 2011
- Annual report, year to Mar 2010Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
Bafna Pharmaceuticals share news and announcements
Newest first. Page 1 of 13.
Sep 2026
Aug 2026
11 Aug · Results
Jun 2026
May 2026
Apr 2026
15 Apr · Legal
The exchange asked on 13 Apr 2026
13 Apr · Significant movement in price has been observed in Bafna Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Price movement
Mar 2026
24 Mar · Legal
The exchange asked on 23 Mar 2026
23 Mar · Significant movement in price has been observed in Bafna Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Price movement
Feb 2026
Jan 2026
Nov 2025
Sep 2025
19 Sep · Management
Aug 2025
12 Aug · Management
12 Aug · Results
Jun 2025
May 2025
26 May · Results
20 May · General Updates
Apr 2025
9 Apr · Updates
1 Apr · Management
1 Apr · Management
Mar 2025
31 Mar · Updates
Feb 2025
6 Feb · Board meeting
How the price met the news
The latest 30. The first session after each announcement, beside the market. Moves to 4 Mar 2016 are on BSE closes, before the company traded on NSE.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 12 Aug 2026Resultsdown 1.99%−2.0 pts vs Nifty 500market median −0.7% · five sessions −9.6% (−8.7 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 1 Jun 2026Resultsup 5.00%+6.0 pts vs Nifty 500market median −0.7% · five sessions +33.7% (+34.5 pts vs Nifty 500) · volume 3.6× usual · The announcement
- 12 Feb 2026Resultsdown 3.50%−2.9 pts vs Nifty 500market median −0.7% · five sessions −9.4% (−8.8 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 27 Jan 2026Credit ratingdown 4.49%−5.0 pts vs Nifty 500market median 0.0% · five sessions −5.0% (−4.6 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 12 Nov 2025Resultsdown 1.97%−2.6 pts vs Nifty 500market median −0.7% · five sessions −9.6% (−10.2 pts vs Nifty 500) · volume 6.9× usual · The announcement
- 13 Aug 2025Resultsup 10.00%+9.4 pts vs Nifty 500market median −0.7% · five sessions +14.6% (+12.1 pts vs Nifty 500) · volume 15.3× usual · delivery −23.1 pts against usual · The announcement
- 27 May 2025Resultsup 2.16%+2.6 pts vs Nifty 500market median −0.7% · five sessions +1.1% (+1.5 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 2 Apr 2025Board or managers changedup 2.35%+1.4 pts vs Nifty 500market median 0.0% · five sessions −3.1% (−0.3 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 3 Oct 2023Board or managers changed–market median 0.0% · five sessions +7.7% (+8.6 pts vs Nifty 500) · volume 2.9× usual · The announcement
- 25 Sep 2023Board or managers changeddown 5.00%−3.1 pts vs Nifty 500market median 0.0% · five sessions +5.1% (+6.9 pts vs Nifty 500) · volume 0.6× usual · The announcement
20 earlier announcements
- 29 May 2023Resultsup 5.00%+4.5 pts vs Nifty 500market median −0.7% · five sessions +27.5% (+26.7 pts vs Nifty 500) · volume 0.8× usual · The announcement
- 20 Jan 2023Board or managers changed0.00%+0.5 pts vs Nifty 500market median 0.0% · five sessions −0.6% (+3.0 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 1 Dec 2022Credit ratingup 1.38%+1.0 pts vs Nifty 500market median 0.0% · five sessions −2.5% (−1.9 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 12 Aug 2022Board or managers changedup 4.98%+4.7 pts vs Nifty 500market median 0.0% · five sessions +10.3% (+9.4 pts vs Nifty 500) · volume 12.3× usual · The announcement
- 22 Mar 2022Board or managers changeddown 0.73%−1.6 pts vs Nifty 500market median 0.0% · five sessions −4.0% (−4.5 pts vs Nifty 500) · volume 0.0× usual · delivery +17.5 pts against usual · The announcement
- 12 Nov 2021Resultsup 0.04%−1.1 pts vs Nifty 500market median −0.7% · five sessions −0.5% (+0.2 pts vs Nifty 500) · volume 1.4× usual · delivery −5.0 pts against usual · The announcement
- 5 Aug 2021Resultsdown 2.09%−2.2 pts vs Nifty 500market median −0.7% · five sessions −7.9% (−7.3 pts vs Nifty 500) · volume 0.7× usual · delivery −19.8 pts against usual · The announcement
- 28 Jun 2021Resultsup 1.04%+1.1 pts vs Nifty 500market median −0.7% · five sessions −2.6% (−2.3 pts vs Nifty 500) · volume 2.1× usual · delivery −8.7 pts against usual · The announcement
- 12 Feb 2021Resultsup 3.19%+3.2 pts vs Nifty 500market median −0.7% · five sessions +25.3% (+24.9 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 13 Nov 2020Resultsup 4.98%+4.5 pts vs Nifty 500market median −0.7% · five sessions +1.8% (+0.5 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 13 Nov 2020Board or managers changedup 4.98%+4.5 pts vs Nifty 500market median 0.0% · five sessions +1.8% (+0.5 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 14 Sep 2020Results0.00%−1.2 pts vs Nifty 500market median −0.7% · five sessions +21.1% (+19.1 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 14 Sep 2020Board or managers changed0.00%−1.2 pts vs Nifty 500market median 0.0% · five sessions +21.1% (+19.1 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 29 Jun 2020Results0.00%0.0 pts vs Nifty 500market median −0.7% · five sessions 0.0% (−6.3 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 29 Jun 2020Board or managers changed0.00%0.0 pts vs Nifty 500market median 0.0% · five sessions 0.0% (−6.3 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 6 Sep 2018Board or managers changedup 0.76%+0.2 pts vs Nifty 500market median 0.0% · five sessions −1.5% (−0.5 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 29 May 2018Board or managers changeddown 3.74%−3.3 pts vs Nifty 500market median 0.0% · five sessions −9.0% (−7.6 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 4 Mar 2016Board or managers changedup 9.11%+8.8 pts vs Nifty 500market median 0.0% · five sessions +9.9% (+9.3 pts vs Nifty 500) · volume 4.8× usual · The announcement
- 19 Nov 2014Credit ratingup 5.77%+6.3 pts vs Nifty 500market median 0.0% · five sessions +7.2% (+7.6 pts vs Nifty 500) · volume 0.8× usual
- 19 May 2014Dividenddown 0.19%−2.1 pts vs Nifty 500market median 0.0% · five sessions +23.1% (+18.4 pts vs Nifty 500) · volume 0.2× usual
Bafna Pharmaceuticals results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.